Evaxion A (EVAX) Change in Working Capital (2020 - 2025)
Evaxion A posted quarterly Change in Working Capital of -$574000.0 for Q2 2025, up 7.42% year-on-year from -$534354.4 in Q2 2024, and up 7.42% on a QoQ basis from -$620000.0 in Q2 2024.
Evaxion A (EVAX) has 6 years of Change in Working Capital data on file, last reported at -$574000.0 in Q2 2025.
- For the quarter ending Q2 2025, Change in Working Capital rose 7.42% year-over-year to -$574000.0; the trailing twelve-month figure through Jun 2025 stood at -$574000.0 (up 7.42% YoY), and the FY2024 full-year result was -$520000.0, up 66.71% from the prior year.
- Change in Working Capital for Q2 2025 stood at -$574000.0, up from -$620000.0 in the prior quarter.
- Across five years, Change in Working Capital topped out at $1.0 million in Q1 2021 and bottomed at -$2.2 million in Q1 2022.
- The 5-year median for Change in Working Capital is -$590000.0 (2021), against an average of -$565500.0.
- The widest annual swing landed in 2021, when Change in Working Capital soared 591.8%; it then tumbled 680.67% in 2022.
- A 5-year view of Change in Working Capital shows it stood at -$606000.0 in 2021, then plunged by 187.46% to -$1.7 million in 2022, then jumped by 91.33% to -$151000.0 in 2023, then sank by 310.6% to -$620000.0 in 2024, then grew by 7.42% to -$574000.0 in 2025.
- The last three Change in Working Capital figures came in at -$574000.0 (Q2 2025), -$620000.0 (Q2 2024), and -$151000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -574,000.00 |
| Jun 30, 2025 | -574,000.00 |
| Jun 30, 2024 | -620,000.00 |
| Jun 30, 2024 | -620,000.00 |
| Jun 30, 2023 | -151,000.00 |
| Jun 30, 2023 | -151,000.00 |
| Jun 30, 2022 | -1.74 Mn |
| Jun 30, 2022 | -1.74 Mn |
| Mar 31, 2022 | -2.17 Mn |
| Mar 31, 2022 | -2.17 Mn |
| Sep 30, 2021 | -606,000.00 |
| Sep 30, 2021 | -606,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 1.04 Mn |
| Mar 31, 2021 | 1.04 Mn |
| Sep 30, 2020 | 105,000.00 |
| Sep 30, 2020 | 105,000.00 |
| Jun 30, 2020 | -61,000.00 |
| Jun 30, 2020 | -61,000.00 |
| Mar 31, 2020 | -358,000.00 |
| Mar 31, 2020 | -358,000.00 |